Company: PCRX
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001396814-25-000061
Chunk: 125

Company: Pacira BioSciences, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part II, Item 6
Chunk 125
---
 or compensatory plan or arrangement.††Certain portions of the exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K. The omitted information (i) is not material and (ii) is the type that the Registrant treats as private or confidential.##Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to supplementally furnish copies of any omitted schedules and exhibits to the Securities and Exchange Commission upon request.(1)Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K, filed on March 14, 2025.(2)Incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K, filed on January 21, 2025.(3)Incorporated by reference to Exhibit 10.2 to the registrant’s Current Report on Form 8-K, filed on January 21, 2025.(4)Incorporated by reference to Exhibit 10.3 to the registrant’s Current Report on Form 8-K, filed on January 21, 2025. 

Pacira BioSciences, Inc.  |  Q1 2025 Form 10-Q  |  Page 53

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

PACIRA BIOSCIENCES, INC.(REGISTRANT)Date:May 8, 2025By: /s/ FRANK D. LEEFrank D. LeeChief Executive Officer and Director(Principal Executive Officer)Date:May 8, 2025By:/s/ SHAWN M. CROSSShawn M. CrossChief Financial Officer(Principal Financial Officer)

Pacira BioSciences, Inc.  |  Q1 2025 Form 10-Q  |  Page 54